Edwards Lifesciences Corp. (EW) reported first quarter adjusted net income of $0.53 per share after the close Tuesday, which was flat with the prior year result. The consensus estimate was for EPS of $0.48. The company expects to report second quarter adjusted EPS of $0.64 to $0.68 and between $2.58 and $2.68 for the full year 2012. The consensus estimates are for EPS of $0.60 and $2.67.
Edwards Lifesciences gapped open higher Wednesday and climbed throughout the first half of the morning. Shares finished up by 8.51 at $81.84 on above average volume. The stock surged to over a 2 1/2 month high.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.